首页
产品目录
分子砌块
按官能团
醇类
4-(3-氨基-6-((1S,3S,4S)-3-氟-4-羟基环己基)吡嗪-2-基)-N-((S)-1-(3-溴-5-氟苯基)-2-(甲氨基)乙基)-2-氟苯甲酰胺
4-(3-氨基-6-((1S,3S,4S)-3-氟-4-羟基环己基)吡嗪-2-基)-N-((S)-1-(3-溴-5-氟苯基)-2-(甲氨基)乙基)-2-氟苯甲酰胺
4-(3-Amino-6-((1S,3S,4S)-3-fluoro-4-hydroxycyclohexyl)pyrazin-2-yl)-N-((S)-1-(3-bromo-5-fluorophenyl)-2-(methylamino)ethyl)-2-fluorobenzamide
产品编号 :
ACLGUC238
Cas No. :
1715025-32-3
包装规格
纯度
目录价
会员专享价
库存
数量
1mg
95%
¥500
询价
5mg
95%
¥1395
询价
10mg
95%
¥2410
询价
25mg
95%
¥3815
询价
100mg
95%
¥7800
询价
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。
基础信息
CAS No.
1715025-32-3
中文名称
4-(3-氨基-6-((1S,3S,4S)-3-氟-4-羟基环己基)吡嗪-2-基)-N-((S)-1-(3-溴-5-氟苯基)-2-(甲氨基)乙基)-2-氟苯甲酰胺
英文名称
4-(3-Amino-6-((1S,3S,4S)-3-fluoro-4-hydroxycyclohexyl)pyrazin-2-yl)-N-((S)-1-(3-bromo-5-fluorophenyl)-2-(methylamino)ethyl)-2-fluorobenzamide
别名
15KFN616FK | EX-A4767 | 1715025-32-3 | CAS-4350-09-8 | CS-0086360 | MS-30393 | Benzamide, 4-(3-amino-6-((1S,3S,4S)-3-fluoro-4-hydroxycyclohexyl)-2-pyrazinyl)-N-((1S)-1-(3-bromo-5-fluorophenyl)-2-(methylamino)ethyl)-2-fluoro- | Rineterkib [INN] | 4-(3-Amin
标准英文名
4-(3-amino-6-((1S,3S,4S)-3-fluoro-4-hydroxycyclohexyl)pyrazin-2-yl)-N-((S)-1-(3-bromo-5-fluorophenyl)-2-(methylamino)ethyl)-2-fluorobenzamide
MDL No.
MFCD31813792
分子式
C2 6 H2 7 BrF3 N5 O2
分子量
578.43
精确分子量
577.13
SMILES
NC1=NC=C(N=C1C2=CC(F)=C(C(N[C@H](CNC)C3=CC(Br)=CC(F)=C3)=O)C=C2)[C@H]4CC[C@H](O)[C@@H](F)C4
标准SMILES
CNC[C@@H](NC(=O)C1C=CC(=CC=1F)C1=NC(=CN=C1N)[C@@H]1C[C@H](F)[C@@H](O)CC1)C1=CC(Br)=CC(F)=C1
用途
Rineterkib (Compound B) is an orally active inhibitor of ERK1 and ERK2, exerting antiproliferative effects by targeting mutations in the MAPK pathway; it is particularly relevant for the treatment of KRAS-mutant non-small cell lung cancer (NSCLC), BRAF-mutant NSCLC, KRAS-mutant pancreatic cancer, KRAS-mutant colorectal cancer, and KRAS-mutant ovarian cancer; Rineterkib hydrochloride also inhibits RAF.
InChIKey
YFCIFWOJYYFDQP-PTWZRHHISA-N